ID   NMDZ1_RAT               Reviewed;         938 AA.
AC   P35439; Q62646;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   02-OCT-2024, entry version 244.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 1;
DE            Short=GluN1;
DE   AltName: Full=Glutamate [NMDA] receptor subunit zeta-1;
DE   AltName: Full=N-methyl-D-aspartate receptor subunit NR1 {ECO:0000303|PubMed:1350383};
DE            Short=NMD-R1;
DE   Flags: Precursor;
GN   Name=Grin1; Synonyms=Nmdar1 {ECO:0000303|PubMed:1834949};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM A), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=1834949; DOI=10.1038/354031a0;
RA   Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S.;
RT   "Molecular cloning and characterization of the rat NMDA receptor.";
RL   Nature 354:31-37(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=1386026; DOI=10.1016/0014-5793(92)80648-z;
RA   Anantharam V., Panchal R., Wilson A., Koltchin V.V., Treistman S.N.,
RA   Bayley H.;
RT   "Combinatorial RNA splicing alters the surface charge on the NMDA
RT   receptor.";
RL   FEBS Lett. 305:27-30(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), ALTERNATIVE SPLICING,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=1388270; DOI=10.1073/pnas.89.18.8552;
RA   Nakanishi N., Axel R., Shneider N.A.;
RT   "Alternative splicing generates functionally distinct N-methyl-D-aspartate
RT   receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8552-8556(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Forebrain;
RX   PubMed=7684237; DOI=10.1016/0896-6273(93)90209-a;
RA   Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G.,
RA   Heinemann S.F.;
RT   "Zinc potentiates agonist-induced currents at certain splice variants of
RT   the NMDA receptor.";
RL   Neuron 10:943-954(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-86.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8399301; DOI=10.1016/0005-2736(93)90249-y;
RA   Bai G., Kusiak J.W.;
RT   "Cloning and analysis of the 5' flanking sequence of the rat N-methyl-D-
RT   aspartate receptor 1 (NMDAR1) gene.";
RL   Biochim. Biophys. Acta 1152:197-200(1993).
RN   [6]
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=1352681; DOI=10.1016/0006-291x(92)91701-q;
RA   Sugihara H., Moriyoshi K., Ishii T., Masu M., Nakanishi S.;
RT   "Structures and properties of seven isoforms of the NMDA receptor generated
RT   by alternative splicing.";
RL   Biochem. Biophys. Res. Commun. 185:826-832(1992).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=1350383; DOI=10.1126/science.256.5060.1217;
RA   Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H.,
RA   Burnashev N., Sakmann B., Seeburg P.H.;
RT   "Heteromeric NMDA receptors: molecular and functional distinction of
RT   subtypes.";
RL   Science 256:1217-1221(1992).
RN   [8]
RP   SUBUNIT, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8428958; DOI=10.1016/s0021-9258(18)53849-7;
RA   Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M.,
RA   Akazawa C., Shigemoto R., Mizuno N., Masu M., Nakanishi S.;
RT   "Molecular characterization of the family of the N-methyl-D-aspartate
RT   receptor subunits.";
RL   J. Biol. Chem. 268:2836-2843(1993).
RN   [9]
RP   PHOSPHORYLATION AT SER-897, DEPHOSPHORYLATION BY PPP2CB, AND IDENTIFICATION
RP   IN A COMPLEX WITH GRIN2A OR GRIN2B; GRIN3A AND PPP2CB.
RX   PubMed=11588171; DOI=10.1523/jneurosci.21-20-07985.2001;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [10]
RP   CHARACTERIZATION, AND IDENTIFICATION IN A COMPLEX WITH GRIN2A OR GRIN2B AND
RP   GRIN3A.
RX   PubMed=11160393; DOI=10.1523/jneurosci.21-04-01228.2001;
RA   Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A., Trimmer J.S.,
RA   Sucher N.J., Heinemann S.F.;
RT   "Assembly with the NR1 subunit is required for surface expression of NR3A-
RT   containing NMDA receptors.";
RL   J. Neurosci. 21:1228-1237(2001).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN2A OR GRIN2B AND GRIN3A.
RX   PubMed=12391275; DOI=10.1124/mol.62.5.1119;
RA   Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B., Yasuda R.P.;
RT   "Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2
RT   subunits.";
RL   Mol. Pharmacol. 62:1119-1127(2002).
RN   [12]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN2A OR GRIN2B AND GRIN3A.
RX   PubMed=11929923; DOI=10.1152/jn.00531.2001;
RA   Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V.,
RA   Wong H.-K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J.,
RA   Lipton S.A.;
RT   "Characterization and comparison of the NR3A subunit of the NMDA receptor
RT   in recombinant systems and primary cortical neurons.";
RL   J. Neurophysiol. 87:2052-2063(2002).
RN   [13]
RP   INTERACTION WITH MPDZ AND DLG4.
RX   PubMed=15312654; DOI=10.1016/j.neuron.2004.08.003;
RA   Krapivinsky G., Medina I., Krapivinsky L., Gapon S., Clapham D.E.;
RT   "SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity
RT   and NMDA receptor-dependent synaptic AMPA receptor potentiation.";
RL   Neuron 43:563-574(2004).
RN   [14]
RP   PHOSPHORYLATION AT SER-890.
RX   PubMed=15936117; DOI=10.1016/j.neuint.2005.04.011;
RA   Sanchez-Perez A.M., Felipo V.;
RT   "Serines 890 and 896 of the NMDA receptor subunit NR1 are differentially
RT   phosphorylated by protein kinase C isoforms.";
RL   Neurochem. Int. 47:84-91(2005).
RN   [15]
RP   INTERACTION WITH LRFN2.
RX   PubMed=16495444; DOI=10.1523/jneurosci.3799-05.2006;
RA   Wang C.Y., Chang K., Petralia R.S., Wang Y.X., Seabold G.K., Wenthold R.J.;
RT   "A novel family of adhesion-like molecules that interacts with the NMDA
RT   receptor.";
RL   J. Neurosci. 26:2174-2183(2006).
RN   [16]
RP   INTERACTION WITH LRFN1.
RX   PubMed=16630835; DOI=10.1016/j.neuron.2006.04.005;
RA   Ko J., Kim S., Chung H.S., Kim K., Han K., Kim H., Jun H., Kaang B.-K.,
RA   Kim E.;
RT   "SALM synaptic cell adhesion-like molecules regulate the differentiation of
RT   excitatory synapses.";
RL   Neuron 50:233-245(2006).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=18177891; DOI=10.1016/j.jmb.2007.11.105;
RA   Schmidt C., Hollmann M.;
RT   "Apparent homomeric NR1 currents observed in Xenopus oocytes are caused by
RT   an endogenous NR2 subunit.";
RL   J. Mol. Biol. 376:658-670(2008).
RN   [18]
RP   INTERACTION WITH MYZAP.
RX   PubMed=18849881; DOI=10.1097/wnr.0b013e328317f05f;
RA   Roginski R.S., Goubaeva F., Mikami M., Fried-Cassorla E., Nair M.R.,
RA   Yang J.;
RT   "GRINL1A colocalizes with N-methyl D-aspartate receptor NR1 subunit and
RT   reduces N-methyl D-aspartate toxicity.";
RL   NeuroReport 19:1721-1726(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-877 (ISOFORM E),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-898 (ISOFORM G), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [20]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-203; ASN-350; ASN-368; ASN-440
RP   AND ASN-771, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
RN   [21]
RP   IDENTIFICATION IN COMPLEX WITH DLG4 AND PRR7, IDENTIFICATION IN A COMPLEX
RP   WITH GRIN2B AND PRR7, AND INTERACTION WITH PRR7.
RX   PubMed=27458189; DOI=10.15252/embj.201593070;
RA   Kravchick D.O., Karpova A., Hrdinka M., Lopez-Rojas J., Iacobas S.,
RA   Carbonell A.U., Iacobas D.A., Kreutz M.R., Jordan B.A.;
RT   "Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates
RT   NMDA-mediated excitotoxicity.";
RL   EMBO J. 35:1923-1934(2016).
RN   [22]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=26912815; DOI=10.1124/mol.115.103036;
RA   Stroebel D., Buhl D.L., Knafels J.D., Chanda P.K., Green M., Sciabola S.,
RA   Mony L., Paoletti P., Pandit J.;
RT   "A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-
RT   selective Antagonists.";
RL   Mol. Pharmacol. 89:541-551(2016).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=28384476; DOI=10.1016/j.neuron.2017.03.018;
RA   Sun W., Hansen K.B., Jahr C.E.;
RT   "Allosteric Interactions between NMDA Receptor Subunits Shape the
RT   Developmental Shift in Channel Properties.";
RL   Neuron 94:58-64(2017).
RN   [24] {ECO:0007744|PDB:1PB7, ECO:0007744|PDB:1PB8, ECO:0007744|PDB:1PB9, ECO:0007744|PDB:1PBQ}
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 394-800 IN COMPLEXES WITH AGONIST
RP   SERINE AND ANTAGONIST, AND DISULFIDE BOND.
RX   PubMed=12805203; DOI=10.1093/emboj/cdg303;
RA   Furukawa H., Gouaux E.;
RT   "Mechanisms of activation, inhibition and specificity: crystal structures
RT   of the NMDA receptor NR1 ligand-binding core.";
RL   EMBO J. 22:2873-2885(2003).
RN   [25] {ECO:0007744|PDB:2A5T}
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 394-800 IN COMPLEX WITH GRIN2A;
RP   GLYCINE AND GLUTAMATE, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=16281028; DOI=10.1038/nature04089;
RA   Furukawa H., Singh S.K., Mancusso R., Gouaux E.;
RT   "Subunit arrangement and function in NMDA receptors.";
RL   Nature 438:185-192(2005).
RN   [26] {ECO:0007744|PDB:1Y1M, ECO:0007744|PDB:1Y1Z, ECO:0007744|PDB:1Y20}
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 394-800 IN COMPLEXES WITH
RP   AGONISTS, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=15996549; DOI=10.1016/j.neuron.2005.05.022;
RA   Inanobe A., Furukawa H., Gouaux E.;
RT   "Mechanism of partial agonist action at the NR1 subunit of NMDA
RT   receptors.";
RL   Neuron 47:71-84(2005).
RN   [27] {ECO:0007744|PDB:3Q41}
RP   X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 21-393, SUBUNIT, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION AT ASN-61; ASN-203; ASN-239; ASN-276 AND ASN-368,
RP   AND DISULFIDE BONDS.
RX   PubMed=21389213; DOI=10.1523/jneurosci.6041-10.2011;
RA   Farina A.N., Blain K.Y., Maruo T., Kwiatkowski W., Choe S., Nakagawa T.;
RT   "Separation of domain contacts is required for heterotetrameric assembly of
RT   functional NMDA receptors.";
RL   J. Neurosci. 31:3565-3579(2011).
RN   [28] {ECO:0007744|PDB:4PE5}
RP   X-RAY CRYSTALLOGRAPHY (3.96 ANGSTROMS) OF 23-847 IN COMPLEX WITH GRIN2B;
RP   GLYCINE AND ALLOSTERIC INHIBITOR, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   TOPOLOGY, GLYCOSYLATION AT ASN-203; ASN-276; ASN-300; ASN-368 AND ASN-440,
RP   AND DISULFIDE BONDS.
RX   PubMed=24876489; DOI=10.1126/science.1251915;
RA   Karakas E., Furukawa H.;
RT   "Crystal structure of a heterotetrameric NMDA receptor ion channel.";
RL   Science 344:992-997(2014).
RN   [29] {ECO:0007744|PDB:5FXG, ECO:0007744|PDB:5FXH, ECO:0007744|PDB:5FXI, ECO:0007744|PDB:5FXJ, ECO:0007744|PDB:5FXK}
RP   STRUCTURE BY ELECTRON MICROSCOPY (6.10 ANGSTROMS) OF 23-847 IN COMPLEX WITH
RP   GRIN2A, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND TOPOLOGY.
RX   PubMed=27135925; DOI=10.1038/nature17679;
RA   Tajima N., Karakas E., Grant T., Simorowski N., Diaz-Avalos R.,
RA   Grigorieff N., Furukawa H.;
RT   "Activation of NMDA receptors and the mechanism of inhibition by
RT   ifenprodil.";
RL   Nature 534:63-68(2016).
RN   [30] {ECO:0007744|PDB:5I56, ECO:0007744|PDB:5I57, ECO:0007744|PDB:5I58, ECO:0007744|PDB:5I59, ECO:0007744|PDB:5JTY}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 394-544 AND 663-800 IN COMPLEXES
RP   WITH GLYCINE AND GRIN2A, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND
RP   DISULFIDE BONDS.
RX   PubMed=27618671; DOI=10.1016/j.neuron.2016.08.014;
RA   Yi F., Mou T.C., Dorsett K.N., Volkmann R.A., Menniti F.S., Sprang S.R.,
RA   Hansen K.B.;
RT   "Structural Basis for Negative Allosteric Modulation of GluN2A-Containing
RT   NMDA Receptors.";
RL   Neuron 91:1316-1329(2016).
RN   [31] {ECO:0007744|PDB:5U8C}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 394-544 AND 663-800 IN COMPLEX
RP   WITH GRIN2A AND SYNTHETIC ANTAGONIST, FUNCTION, SUBCELLULAR LOCATION,
RP   SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=28468946; DOI=10.1124/mol.116.107912;
RA   Romero-Hernandez A., Furukawa H.;
RT   "Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the Crystal
RT   Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed to NVP-
RT   AAM077.";
RL   Mol. Pharmacol. 92:22-29(2017).
RN   [32] {ECO:0007744|PDB:5DEX, ECO:0007744|PDB:5VIH, ECO:0007744|PDB:5VII, ECO:0007744|PDB:5VIJ}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 394-544 AND 663-800 IN COMPLEX
RP   WITH GRIN2A AND GLYCINE, AND DISULFIDE BONDS.
RA   Mou T.C., Sprang S.R., Hansen K.B.;
RT   "Crystal structure of GluN1/GluN2A NMDA receptor agonist binding domains
RT   with glycine and antagonist, phenyl-ACEPC.";
RL   Submitted (APR-2017) to the PDB data bank.
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium. Channel
CC       activation requires binding of the neurotransmitter glutamate to the
CC       epsilon subunit, glycine binding to the zeta subunit, plus membrane
CC       depolarization to eliminate channel inhibition by Mg(2+)
CC       (PubMed:1350383, PubMed:1388270, PubMed:15996549, PubMed:18177891,
CC       PubMed:1834949, PubMed:24876489, PubMed:27135925, PubMed:27618671,
CC       PubMed:28384476, PubMed:28468946, PubMed:8428958). Sensitivity to
CC       glutamate and channel kinetics depend on the subunit composition
CC       (PubMed:28384476). {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:1388270, ECO:0000269|PubMed:15996549,
CC       ECO:0000269|PubMed:18177891, ECO:0000269|PubMed:1834949,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27618671, ECO:0000269|PubMed:28384476,
CC       ECO:0000269|PubMed:28468946, ECO:0000269|PubMed:8428958}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed of
CC       two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A, GRIN2B,
CC       GRIN2C or GRIN2D) (in vitro) (PubMed:15996549, PubMed:16281028,
CC       PubMed:18177891, PubMed:21389213, PubMed:24876489, PubMed:27135925,
CC       PubMed:28384476, PubMed:28468946, Ref.32). Can also form
CC       heterotetrameric channels that contain at least one zeta subunit
CC       (GRIN1), an epsilon subunit, plus GRIN3A or GRIN3B (in vitro)
CC       (PubMed:11160393, PubMed:11929923, PubMed:12391275). In vivo, the
CC       subunit composition may vary in function of the expression levels of
CC       the different subunits (Probable). Found in a complex with GRIN2A or
CC       GRIN2B, GRIN3A and PPP2CB (PubMed:11588171). Found in a complex with
CC       GRIN2A or GRIN2B and GRIN3B (By similarity). Interacts with SNX27 (via
CC       PDZ domain); the interaction is required for recycling to the plasma
CC       membrane when endocytosed and prevent degradation in lysosomes (By
CC       similarity). Interacts with DLG4 and MPDZ (PubMed:15312654). Interacts
CC       with LRFN1 and LRFN2 (PubMed:16495444, PubMed:16630835). Interacts with
CC       MYZAP (PubMed:18849881). Found in a complex with DLG4 and PRR7
CC       (PubMed:27458189). Found in a complex with GRIN2B and PRR7
CC       (PubMed:27458189). Interacts with PRR7; the interaction is reduced
CC       following NMDA receptor activity (PubMed:27458189).
CC       {ECO:0000250|UniProtKB:P35438, ECO:0000269|PubMed:11160393,
CC       ECO:0000269|PubMed:11588171, ECO:0000269|PubMed:11929923,
CC       ECO:0000269|PubMed:12391275, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:15312654, ECO:0000269|PubMed:15996549,
CC       ECO:0000269|PubMed:16281028, ECO:0000269|PubMed:16495444,
CC       ECO:0000269|PubMed:16630835, ECO:0000269|PubMed:18177891,
CC       ECO:0000269|PubMed:18849881, ECO:0000269|PubMed:21389213,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27458189, ECO:0000269|PubMed:27618671,
CC       ECO:0000269|PubMed:28384476, ECO:0000269|PubMed:28468946,
CC       ECO:0000269|PubMed:8428958, ECO:0000269|Ref.32, ECO:0000305}.
CC   -!- INTERACTION:
CC       P35439; P31016: Dlg4; NbExp=4; IntAct=EBI-877897, EBI-375655;
CC       P35439; Q00960: Grin2b; NbExp=13; IntAct=EBI-877897, EBI-396905;
CC       P35439; Q460M5: Lrfn2; NbExp=2; IntAct=EBI-877897, EBI-877185;
CC       P35439; Q9JJ40: Pdzk1; NbExp=3; IntAct=EBI-877897, EBI-7713572;
CC       P35439; Q80TG9: Lrfn2; Xeno; NbExp=2; IntAct=EBI-877897, EBI-877092;
CC       P35439-1; Q80TG9: Lrfn2; Xeno; NbExp=2; IntAct=EBI-877923, EBI-877092;
CC       P35439-4; Q80TG9: Lrfn2; Xeno; NbExp=2; IntAct=EBI-877935, EBI-877092;
CC       P35439-7; Q00960: Grin2b; NbExp=2; IntAct=EBI-15932497, EBI-396905;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:1388270, ECO:0000269|PubMed:15996549,
CC       ECO:0000269|PubMed:18177891, ECO:0000269|PubMed:1834949,
CC       ECO:0000269|PubMed:21389213, ECO:0000269|PubMed:24876489,
CC       ECO:0000269|PubMed:27135925, ECO:0000269|PubMed:27618671,
CC       ECO:0000269|PubMed:28384476, ECO:0000269|PubMed:28468946,
CC       ECO:0000269|PubMed:8428958}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925}.
CC       Postsynaptic cell membrane {ECO:0000250}. Postsynaptic density
CC       {ECO:0000250}. Note=Enriched in postsynaptic plasma membrane and
CC       postsynaptic densities. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=A;
CC         IsoId=P35439-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P35439-2; Sequence=VSP_000140;
CC       Name=C; Synonyms=NMDAR1-2a subunit;
CC         IsoId=P35439-3; Sequence=VSP_000141;
CC       Name=D;
CC         IsoId=P35439-4; Sequence=VSP_000144;
CC       Name=E;
CC         IsoId=P35439-5; Sequence=VSP_000142, VSP_000143;
CC       Name=F; Synonyms=NMDAR1-2b subunit;
CC         IsoId=P35439-6; Sequence=VSP_000140, VSP_000141;
CC       Name=G; Synonyms=NMDAR1-4b subunit;
CC         IsoId=P35439-7; Sequence=VSP_000140, VSP_000142, VSP_000143;
CC   -!- TISSUE SPECIFICITY: Detected throughout the brain, in brain cortex,
CC       cerebellum, thalamus and olfactory bulb. {ECO:0000269|PubMed:1350383}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of a
CC       transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:A0A1L8F5J9}.
CC   -!- PTM: NMDA is probably regulated by C-terminal phosphorylation of an
CC       isoform of NR1 by PKC. Dephosphorylated on Ser-897 probably by protein
CC       phosphatase 2A (PPP2CB). Its phosphorylated state is influenced by the
CC       formation of the NMDAR-PPP2CB complex and the NMDAR channel activity.
CC       {ECO:0000269|PubMed:11588171, ECO:0000269|PubMed:15936117}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. NR1/GRIN1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63255; CAA44914.1; -; mRNA.
DR   EMBL; AY157515; AAA16366.1; -; Genomic_DNA.
DR   EMBL; X65227; CAA46335.1; -; mRNA.
DR   EMBL; U08261; AAB50926.1; -; mRNA.
DR   EMBL; U08262; AAB50927.1; -; mRNA.
DR   EMBL; U08263; AAB50928.1; -; mRNA.
DR   EMBL; U08264; AAB50929.1; -; mRNA.
DR   EMBL; U08265; AAB50930.1; -; mRNA.
DR   EMBL; U08267; AAB50932.1; -; mRNA.
DR   EMBL; U08268; AAB50933.1; -; mRNA.
DR   EMBL; S39217; AAB22431.1; -; mRNA.
DR   EMBL; S39218; AAB22432.1; -; mRNA.
DR   EMBL; S39219; AAB22433.1; -; mRNA.
DR   EMBL; S39220; AAB22434.1; -; mRNA.
DR   EMBL; S39221; AAB22435.1; -; mRNA.
DR   PIR; JN0336; JN0336.
DR   PIR; JN0337; JN0337.
DR   PIR; JN0338; JN0338.
DR   PIR; JN0339; JN0339.
DR   PIR; JN0340; JN0340.
DR   PIR; JN0341; JN0341.
DR   PIR; JN0342; JN0342.
DR   PIR; S19710; S19710.
DR   RefSeq; NP_001257531.1; NM_001270602.1. [P35439-2]
DR   RefSeq; NP_001257532.1; NM_001270603.1. [P35439-6]
DR   RefSeq; NP_001257534.1; NM_001270605.1. [P35439-3]
DR   RefSeq; NP_001257537.1; NM_001270608.1. [P35439-7]
DR   RefSeq; NP_001257539.1; NM_001270610.1. [P35439-5]
DR   RefSeq; NP_001274352.1; NM_001287423.1. [P35439-4]
DR   RefSeq; NP_058706.1; NM_017010.2. [P35439-1]
DR   PDB; 1PB7; X-ray; 1.35 A; A=394-544, A=663-800.
DR   PDB; 1PB8; X-ray; 1.45 A; A=394-544, A=663-800.
DR   PDB; 1PB9; X-ray; 1.60 A; A=394-544, A=663-800.
DR   PDB; 1PBQ; X-ray; 1.90 A; A/B=394-544, A/B=663-800.
DR   PDB; 1Y1M; X-ray; 1.80 A; A/B=394-544, A/B=663-800.
DR   PDB; 1Y1Z; X-ray; 1.50 A; A=394-544, A=663-800.
DR   PDB; 1Y20; X-ray; 1.40 A; A=394-544, A=663-800.
DR   PDB; 2A5T; X-ray; 2.00 A; A=394-544.
DR   PDB; 3Q41; X-ray; 3.40 A; A/B/C=21-393.
DR   PDB; 4KCC; X-ray; 1.89 A; A=394-544, A=663-800.
DR   PDB; 4KFQ; X-ray; 2.20 A; A/B=394-544, A/B=663-800.
DR   PDB; 4NF4; X-ray; 2.00 A; A=394-544, A=663-800.
DR   PDB; 4NF5; X-ray; 1.90 A; A=394-544, A=663-800.
DR   PDB; 4NF6; X-ray; 2.10 A; A=394-544, A=663-800.
DR   PDB; 4NF8; X-ray; 1.86 A; A=394-544, A=663-800.
DR   PDB; 4PE5; X-ray; 3.96 A; A/C=23-847.
DR   PDB; 5DEX; X-ray; 2.40 A; A=394-544, A=663-800.
DR   PDB; 5FXG; EM; 6.80 A; A/C=23-863.
DR   PDB; 5FXH; EM; 6.10 A; A/C=23-863.
DR   PDB; 5FXI; EM; 6.40 A; A/C=23-863.
DR   PDB; 5FXJ; EM; 6.50 A; A/C=23-863.
DR   PDB; 5FXK; EM; 6.40 A; A/C=23-863.
DR   PDB; 5I56; X-ray; 2.28 A; A=394-544, A=663-800.
DR   PDB; 5I57; X-ray; 1.70 A; A=394-544, A=684-821.
DR   PDB; 5I58; X-ray; 2.52 A; A=394-544, A=663-800.
DR   PDB; 5I59; X-ray; 2.25 A; A=394-544, A=663-800.
DR   PDB; 5JTY; X-ray; 2.72 A; A=394-544, A=684-821.
DR   PDB; 5U8C; X-ray; 1.60 A; A=394-544, A=663-800.
DR   PDB; 5VIH; X-ray; 2.40 A; A=394-544, A=663-800.
DR   PDB; 5VII; X-ray; 1.95 A; A=394-544, A=663-800.
DR   PDB; 5VIJ; X-ray; 2.10 A; A=394-544, A=663-800.
DR   PDB; 6CNA; EM; 4.60 A; A/C=25-838.
DR   PDB; 6MM9; EM; 5.97 A; A/C=1-838.
DR   PDB; 6MMA; EM; 6.31 A; A/C=1-838.
DR   PDB; 6MMB; EM; 12.70 A; A/C=1-838.
DR   PDB; 6MMG; EM; 6.23 A; A/C=1-838.
DR   PDB; 6MMH; EM; 8.21 A; A/C=1-838.
DR   PDB; 6MMI; EM; 8.93 A; A/C=1-838.
DR   PDB; 6MMJ; EM; 16.50 A; A/C=1-838.
DR   PDB; 6MMK; EM; 6.08 A; A/C=1-838.
DR   PDB; 6MML; EM; 7.14 A; A/C=1-838.
DR   PDB; 6MMM; EM; 6.84 A; A/C=1-838.
DR   PDB; 6MMN; EM; 7.51 A; A/C=1-838.
DR   PDB; 6MMP; EM; 6.88 A; A/C=1-838.
DR   PDB; 6MMR; EM; 5.13 A; A/C=1-838.
DR   PDB; 6MMS; EM; 5.38 A; A/C=1-838.
DR   PDB; 6MMT; EM; 7.46 A; A/C=1-838.
DR   PDB; 6MMU; EM; 5.30 A; A/C=1-838.
DR   PDB; 6MMV; EM; 4.71 A; A/C=1-797.
DR   PDB; 6MMW; EM; 6.20 A; A/C=1-838.
DR   PDB; 6MMX; EM; 6.99 A; A/C=1-838.
DR   PDB; 6OVD; X-ray; 2.10 A; A=394-544, A=663-800.
DR   PDB; 6OVE; X-ray; 2.00 A; A=394-544, A=663-800.
DR   PDB; 6USU; X-ray; 2.09 A; A=394-544, A=663-800.
DR   PDB; 6USV; X-ray; 2.30 A; A=394-544, A=663-800.
DR   PDB; 6UZ6; X-ray; 1.66 A; A=394-544, A=663-800.
DR   PDB; 6UZG; X-ray; 1.94 A; A=394-544, A=663-800.
DR   PDB; 6UZR; X-ray; 1.87 A; A=394-544, A=663-800.
DR   PDB; 6UZW; X-ray; 2.13 A; A=394-544, A=663-800.
DR   PDB; 6UZX; X-ray; 2.41 A; A=394-544, A=663-800.
DR   PDB; 6WHR; EM; 3.99 A; A/C=1-938.
DR   PDB; 6WHS; EM; 4.00 A; A/C=1-938.
DR   PDB; 6WHT; EM; 4.39 A; A/C=1-938.
DR   PDB; 6WHU; EM; 3.93 A; A/C=1-938.
DR   PDB; 6WHV; EM; 4.05 A; A/C=1-938.
DR   PDB; 6WHW; EM; 4.09 A; A/C=1-938.
DR   PDB; 6WHX; EM; 4.09 A; A/C=1-938.
DR   PDB; 6WHY; EM; 4.03 A; A/C=1-938.
DR   PDB; 6WI0; EM; 4.27 A; A/C=1-938.
DR   PDB; 6WI1; EM; 3.62 A; A/C=1-847.
DR   PDB; 7SAA; EM; 2.97 A; A/C=1-847.
DR   PDB; 7SAB; EM; 4.30 A; A/C=1-847.
DR   PDB; 7SAC; EM; 3.69 A; A/C=1-847.
DR   PDB; 7SAD; EM; 3.96 A; A/C=1-847.
DR   PDB; 7TE9; EM; 3.92 A; A/C=1-838.
DR   PDB; 7TEB; EM; 4.23 A; A/C=1-838.
DR   PDB; 7TEE; EM; 6.59 A; A/C=1-838.
DR   PDB; 7TEQ; EM; 7.51 A; A/C=1-838.
DR   PDB; 7TER; EM; 5.23 A; A/C=1-838.
DR   PDB; 7TES; EM; 4.70 A; A/C=1-838.
DR   PDB; 7TET; EM; 4.45 A; A/C=1-838.
DR   PDB; 7YFG; EM; 3.60 A; A/C=1-847.
DR   PDB; 7YFH; EM; 3.00 A; A/C=1-847.
DR   PDB; 7YFI; EM; 3.30 A; A/C=1-798.
DR   PDB; 8HDK; EM; 4.30 A; A/C=1-796.
DR   PDB; 8JF7; EM; 7.73 A; A/C=1-847.
DR   PDB; 8USW; EM; 4.23 A; A/C=1-847.
DR   PDBsum; 1PB7; -.
DR   PDBsum; 1PB8; -.
DR   PDBsum; 1PB9; -.
DR   PDBsum; 1PBQ; -.
DR   PDBsum; 1Y1M; -.
DR   PDBsum; 1Y1Z; -.
DR   PDBsum; 1Y20; -.
DR   PDBsum; 2A5T; -.
DR   PDBsum; 3Q41; -.
DR   PDBsum; 4KCC; -.
DR   PDBsum; 4KFQ; -.
DR   PDBsum; 4NF4; -.
DR   PDBsum; 4NF5; -.
DR   PDBsum; 4NF6; -.
DR   PDBsum; 4NF8; -.
DR   PDBsum; 4PE5; -.
DR   PDBsum; 5DEX; -.
DR   PDBsum; 5FXG; -.
DR   PDBsum; 5FXH; -.
DR   PDBsum; 5FXI; -.
DR   PDBsum; 5FXJ; -.
DR   PDBsum; 5FXK; -.
DR   PDBsum; 5I56; -.
DR   PDBsum; 5I57; -.
DR   PDBsum; 5I58; -.
DR   PDBsum; 5I59; -.
DR   PDBsum; 5JTY; -.
DR   PDBsum; 5U8C; -.
DR   PDBsum; 5VIH; -.
DR   PDBsum; 5VII; -.
DR   PDBsum; 5VIJ; -.
DR   PDBsum; 6CNA; -.
DR   PDBsum; 6MM9; -.
DR   PDBsum; 6MMA; -.
DR   PDBsum; 6MMB; -.
DR   PDBsum; 6MMG; -.
DR   PDBsum; 6MMH; -.
DR   PDBsum; 6MMI; -.
DR   PDBsum; 6MMJ; -.
DR   PDBsum; 6MMK; -.
DR   PDBsum; 6MML; -.
DR   PDBsum; 6MMM; -.
DR   PDBsum; 6MMN; -.
DR   PDBsum; 6MMP; -.
DR   PDBsum; 6MMR; -.
DR   PDBsum; 6MMS; -.
DR   PDBsum; 6MMT; -.
DR   PDBsum; 6MMU; -.
DR   PDBsum; 6MMV; -.
DR   PDBsum; 6MMW; -.
DR   PDBsum; 6MMX; -.
DR   PDBsum; 6OVD; -.
DR   PDBsum; 6OVE; -.
DR   PDBsum; 6USU; -.
DR   PDBsum; 6USV; -.
DR   PDBsum; 6UZ6; -.
DR   PDBsum; 6UZG; -.
DR   PDBsum; 6UZR; -.
DR   PDBsum; 6UZW; -.
DR   PDBsum; 6UZX; -.
DR   PDBsum; 6WHR; -.
DR   PDBsum; 6WHS; -.
DR   PDBsum; 6WHT; -.
DR   PDBsum; 6WHU; -.
DR   PDBsum; 6WHV; -.
DR   PDBsum; 6WHW; -.
DR   PDBsum; 6WHX; -.
DR   PDBsum; 6WHY; -.
DR   PDBsum; 6WI0; -.
DR   PDBsum; 6WI1; -.
DR   PDBsum; 7SAA; -.
DR   PDBsum; 7SAB; -.
DR   PDBsum; 7SAC; -.
DR   PDBsum; 7SAD; -.
DR   PDBsum; 7TE9; -.
DR   PDBsum; 7TEB; -.
DR   PDBsum; 7TEE; -.
DR   PDBsum; 7TEQ; -.
DR   PDBsum; 7TER; -.
DR   PDBsum; 7TES; -.
DR   PDBsum; 7TET; -.
DR   PDBsum; 7YFG; -.
DR   PDBsum; 7YFH; -.
DR   PDBsum; 7YFI; -.
DR   PDBsum; 8HDK; -.
DR   PDBsum; 8JF7; -.
DR   PDBsum; 8USW; -.
DR   AlphaFoldDB; P35439; -.
DR   EMDB; EMD-21673; -.
DR   EMDB; EMD-21674; -.
DR   EMDB; EMD-21675; -.
DR   EMDB; EMD-21676; -.
DR   EMDB; EMD-21677; -.
DR   EMDB; EMD-21678; -.
DR   EMDB; EMD-21679; -.
DR   EMDB; EMD-21680; -.
DR   EMDB; EMD-21681; -.
DR   EMDB; EMD-21682; -.
DR   EMDB; EMD-24946; -.
DR   EMDB; EMD-24947; -.
DR   EMDB; EMD-24948; -.
DR   EMDB; EMD-24949; -.
DR   EMDB; EMD-25843; -.
DR   EMDB; EMD-25844; -.
DR   EMDB; EMD-25845; -.
DR   EMDB; EMD-25849; -.
DR   EMDB; EMD-25850; -.
DR   EMDB; EMD-25851; -.
DR   EMDB; EMD-25852; -.
DR   EMDB; EMD-3352; -.
DR   EMDB; EMD-3353; -.
DR   EMDB; EMD-3354; -.
DR   EMDB; EMD-3355; -.
DR   EMDB; EMD-3356; -.
DR   EMDB; EMD-33789; -.
DR   EMDB; EMD-33790; -.
DR   EMDB; EMD-33791; -.
DR   EMDB; EMD-34674; -.
DR   EMDB; EMD-36209; -.
DR   EMDB; EMD-42520; -.
DR   EMDB; EMD-7529; -.
DR   EMDB; EMD-9147; -.
DR   EMDB; EMD-9148; -.
DR   EMDB; EMD-9149; -.
DR   EMDB; EMD-9150; -.
DR   EMDB; EMD-9151; -.
DR   EMDB; EMD-9152; -.
DR   EMDB; EMD-9153; -.
DR   EMDB; EMD-9154; -.
DR   EMDB; EMD-9155; -.
DR   EMDB; EMD-9156; -.
DR   EMDB; EMD-9157; -.
DR   EMDB; EMD-9158; -.
DR   EMDB; EMD-9159; -.
DR   EMDB; EMD-9160; -.
DR   EMDB; EMD-9161; -.
DR   EMDB; EMD-9162; -.
DR   EMDB; EMD-9163; -.
DR   EMDB; EMD-9164; -.
DR   EMDB; EMD-9165; -.
DR   SMR; P35439; -.
DR   BioGRID; 246573; 24.
DR   ComplexPortal; CPX-283; NMDA receptor complex, GluN1-GluN2A.
DR   ComplexPortal; CPX-284; NMDA receptor complex, GluN1-GluN2B.
DR   ComplexPortal; CPX-287; NMDA receptor complex, GluN1-GluN2C.
DR   ComplexPortal; CPX-288; NMDA receptor complex, GluN1-GluN2D.
DR   ComplexPortal; CPX-295; NMDA receptor complex, GluN1-GluN2A-GluN2B.
DR   CORUM; P35439; -.
DR   DIP; DIP-674N; -.
DR   IntAct; P35439; 19.
DR   MINT; P35439; -.
DR   STRING; 10116.ENSRNOP00000029227; -.
DR   BindingDB; P35439; -.
DR   ChEMBL; CHEMBL330; -.
DR   DrugCentral; P35439; -.
DR   GuidetoPHARMACOLOGY; 455; -.
DR   TCDB; 1.A.10.1.6; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   GlyCosmos; P35439; 12 sites, 12 glycans.
DR   GlyGen; P35439; 12 sites, 12 N-linked glycans (5 sites).
DR   iPTMnet; P35439; -.
DR   PhosphoSitePlus; P35439; -.
DR   PaxDb; 10116-ENSRNOP00000029227; -.
DR   ABCD; P35439; 9 sequenced antibodies.
DR   Ensembl; ENSRNOT00000037725.6; ENSRNOP00000029227.5; ENSRNOG00000011726.8. [P35439-2]
DR   Ensembl; ENSRNOT00000044246.5; ENSRNOP00000043301.3; ENSRNOG00000011726.8. [P35439-6]
DR   Ensembl; ENSRNOT00000049297.4; ENSRNOP00000049198.1; ENSRNOG00000011726.8. [P35439-1]
DR   Ensembl; ENSRNOT00055000870; ENSRNOP00055000684; ENSRNOG00055000504. [P35439-1]
DR   Ensembl; ENSRNOT00060054953; ENSRNOP00060045438; ENSRNOG00060031665. [P35439-1]
DR   Ensembl; ENSRNOT00065043348; ENSRNOP00065035543; ENSRNOG00065025127. [P35439-1]
DR   GeneID; 24408; -.
DR   KEGG; rno:24408; -.
DR   UCSC; RGD:2736; rat. [P35439-1]
DR   AGR; RGD:2736; -.
DR   CTD; 2902; -.
DR   RGD; 2736; Grin1.
DR   eggNOG; KOG4440; Eukaryota.
DR   GeneTree; ENSGT00940000158016; -.
DR   HOGENOM; CLU_007257_2_0_1; -.
DR   InParanoid; P35439; -.
DR   OMA; AYKKHQI; -.
DR   OrthoDB; 1034721at2759; -.
DR   PhylomeDB; P35439; -.
DR   TreeFam; TF351405; -.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   Reactome; R-RNO-9609736; Assembly and cell surface presentation of NMDA receptors.
DR   EvolutionaryTrace; P35439; -.
DR   PRO; PR:P35439; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000011726; Expressed in frontal cortex and 9 other cell types or tissues.
DR   ExpressionAtlas; P35439; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:BHF-UCL.
DR   GO; GO:0044307; C:dendritic branch; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0043083; C:synaptic cleft; IDA:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; IDA:ARUK-UCL.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0016595; F:glutamate binding; IDA:UniProtKB.
DR   GO; GO:0035254; F:glutamate receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISO:RGD.
DR   GO; GO:0004970; F:glutamate-gated receptor activity; IDA:RGD.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated monoatomic ion channel activity; IBA:GO_Central.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0005261; F:monoatomic cation channel activity; ISO:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0022843; F:voltage-gated monoatomic cation channel activity; IMP:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; ISO:RGD.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:1905430; P:cellular response to glycine; IEP:RGD.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0001661; P:conditioned taste aversion; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; ISO:RGD.
DR   GO; GO:0007616; P:long-term memory; ISO:RGD.
DR   GO; GO:0060179; P:male mating behavior; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0098655; P:monoatomic cation transmembrane transport; IDA:ComplexPortal.
DR   GO; GO:0006812; P:monoatomic cation transport; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0050905; P:neuromuscular process; ISO:RGD.
DR   GO; GO:0070050; P:neuron cellular homeostasis; ISO:RGD.
DR   GO; GO:0008355; P:olfactory learning; ISO:RGD.
DR   GO; GO:0021586; P:pons maturation; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IGI:ARUK-UCL.
DR   GO; GO:1902952; P:positive regulation of dendritic spine maintenance; IGI:ARUK-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:BHF-UCL.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; IGI:ARUK-UCL.
DR   GO; GO:1900149; P:positive regulation of Schwann cell migration; IMP:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IDA:ComplexPortal.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0018964; P:propylene metabolic process; ISO:RGD.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:1903539; P:protein localization to postsynaptic membrane; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:RGD.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISO:RGD.
DR   GO; GO:0010646; P:regulation of cell communication; ISO:RGD.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:1904062; P:regulation of monoatomic cation transmembrane transport; IDA:ComplexPortal.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; ISO:RGD.
DR   GO; GO:0051963; P:regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; ISO:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:1905429; P:response to glycine; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0043278; P:response to morphine; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IDA:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   GO; GO:0035176; P:social behavior; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0001967; P:suckling behavior; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   CDD; cd06379; PBP1_iGluR_NMDA_NR1; 1.
DR   CDD; cd13719; PBP2_iGluR_NMDA_Nr1; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.40.190.10; Periplasmic binding protein-like II; 3.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_Glu_rcpt_met.
DR   InterPro; IPR015683; Ionotropic_Glu_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt_C.
DR   InterPro; IPR049872; NMDA1-like_ligand-bd.
DR   InterPro; IPR049873; NMDA1-like_N.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR18966:SF377; GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1; 1.
DR   PANTHER; PTHR18966; IONOTROPIC GLUTAMATE RECEPTOR; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF53850; Periplasmic binding protein-like II; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Magnesium; Membrane; Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..938
FT                   /note="Glutamate receptor ionotropic, NMDA 1"
FT                   /id="PRO_0000011589"
FT   TOPO_DOM        19..559
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TRANSMEM        560..580
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TOPO_DOM        581..602
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   INTRAMEM        603..624
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000250|UniProtKB:A0A1L8F5J9"
FT   TOPO_DOM        625..630
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TRANSMEM        631..647
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TOPO_DOM        648..812
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TRANSMEM        813..833
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TOPO_DOM        834..938
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   REGION          603..624
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:A0A1L8F5J9"
FT   REGION          889..938
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        917..938
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         516..518
FT                   /ligand="glycine"
FT                   /ligand_id="ChEBI:CHEBI:57305"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:1PB7, ECO:0007744|PDB:2A5T,
FT                   ECO:0007744|PDB:4NF5, ECO:0007744|PDB:4NF6,
FT                   ECO:0007744|PDB:4NF8, ECO:0007744|PDB:4PE5,
FT                   ECO:0007744|PDB:5DEX, ECO:0007744|PDB:5I56,
FT                   ECO:0007744|PDB:5I57, ECO:0007744|PDB:5I58,
FT                   ECO:0007744|PDB:5I59, ECO:0007744|PDB:5U8C,
FT                   ECO:0007744|PDB:5VIH, ECO:0007744|PDB:5VII,
FT                   ECO:0007744|PDB:5VIJ"
FT   BINDING         523
FT                   /ligand="glycine"
FT                   /ligand_id="ChEBI:CHEBI:57305"
FT                   /evidence="ECO:0000269|PubMed:16281028,
FT                   ECO:0000269|PubMed:24876489, ECO:0007744|PDB:1PB7,
FT                   ECO:0007744|PDB:2A5T, ECO:0007744|PDB:4NF5,
FT                   ECO:0007744|PDB:4NF6, ECO:0007744|PDB:4NF8,
FT                   ECO:0007744|PDB:4PE5, ECO:0007744|PDB:5DEX,
FT                   ECO:0007744|PDB:5I56, ECO:0007744|PDB:5I57,
FT                   ECO:0007744|PDB:5I58, ECO:0007744|PDB:5I59,
FT                   ECO:0007744|PDB:5U8C, ECO:0007744|PDB:5VIH,
FT                   ECO:0007744|PDB:5VII, ECO:0007744|PDB:5VIJ"
FT   BINDING         688
FT                   /ligand="glycine"
FT                   /ligand_id="ChEBI:CHEBI:57305"
FT                   /evidence="ECO:0000269|PubMed:16281028,
FT                   ECO:0000269|PubMed:24876489, ECO:0007744|PDB:1PB7,
FT                   ECO:0007744|PDB:2A5T, ECO:0007744|PDB:4NF5,
FT                   ECO:0007744|PDB:4NF6, ECO:0007744|PDB:4NF8,
FT                   ECO:0007744|PDB:4PE5, ECO:0007744|PDB:5DEX,
FT                   ECO:0007744|PDB:5I56, ECO:0007744|PDB:5I57,
FT                   ECO:0007744|PDB:5I58, ECO:0007744|PDB:5I59,
FT                   ECO:0007744|PDB:5U8C, ECO:0007744|PDB:5VIH,
FT                   ECO:0007744|PDB:5VII, ECO:0007744|PDB:5VIJ"
FT   BINDING         732
FT                   /ligand="glycine"
FT                   /ligand_id="ChEBI:CHEBI:57305"
FT                   /evidence="ECO:0000269|PubMed:16281028,
FT                   ECO:0000269|PubMed:24876489, ECO:0007744|PDB:1PB7,
FT                   ECO:0007744|PDB:2A5T, ECO:0007744|PDB:4NF5,
FT                   ECO:0007744|PDB:4NF6, ECO:0007744|PDB:4NF8,
FT                   ECO:0007744|PDB:4PE5, ECO:0007744|PDB:5DEX,
FT                   ECO:0007744|PDB:5I56, ECO:0007744|PDB:5I57,
FT                   ECO:0007744|PDB:5I58, ECO:0007744|PDB:5I59,
FT                   ECO:0007744|PDB:5U8C, ECO:0007744|PDB:5VIH,
FT                   ECO:0007744|PDB:5VII, ECO:0007744|PDB:5VIJ"
FT   MOD_RES         889
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:Q05586"
FT   MOD_RES         890
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:15936117"
FT   MOD_RES         896
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:Q05586"
FT   MOD_RES         897
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:11588171"
FT   CARBOHYD        61
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PDB:3Q41"
FT   CARBOHYD        203
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:3Q41, ECO:0007744|PDB:4PE5,
FT                   ECO:0007744|PubMed:24090084"
FT   CARBOHYD        239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PDB:3Q41"
FT   CARBOHYD        276
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:3Q41, ECO:0007744|PDB:4PE5"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   CARBOHYD        350
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        368
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:3Q41, ECO:0007744|PDB:4PE5,
FT                   ECO:0007744|PubMed:24090084"
FT   CARBOHYD        440
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5, ECO:0007744|PubMed:24090084"
FT   CARBOHYD        471
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        491
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        674
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        771
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   DISULFID        79..308
FT                   /evidence="ECO:0007744|PDB:3Q41, ECO:0007744|PDB:4PE5"
FT   DISULFID        420..454
FT                   /evidence="ECO:0007744|PDB:1PB7, ECO:0007744|PDB:1PB8,
FT                   ECO:0007744|PDB:1PB9, ECO:0007744|PDB:1PBQ,
FT                   ECO:0007744|PDB:1Y1M, ECO:0007744|PDB:1Y1Z,
FT                   ECO:0007744|PDB:1Y20, ECO:0007744|PDB:2A5T,
FT                   ECO:0007744|PDB:4KCC, ECO:0007744|PDB:4KFQ,
FT                   ECO:0007744|PDB:4NF4, ECO:0007744|PDB:4NF5,
FT                   ECO:0007744|PDB:4NF8, ECO:0007744|PDB:4PE5,
FT                   ECO:0007744|PDB:5DEX, ECO:0007744|PDB:5I56,
FT                   ECO:0007744|PDB:5I57, ECO:0007744|PDB:5I58,
FT                   ECO:0007744|PDB:5I59, ECO:0007744|PDB:5JTY,
FT                   ECO:0007744|PDB:5U8C, ECO:0007744|PDB:5VIH,
FT                   ECO:0007744|PDB:5VII, ECO:0007744|PDB:5VIJ"
FT   DISULFID        436..455
FT                   /evidence="ECO:0007744|PDB:1PB7, ECO:0007744|PDB:1PB8,
FT                   ECO:0007744|PDB:1PB9, ECO:0007744|PDB:1PBQ,
FT                   ECO:0007744|PDB:1Y1M, ECO:0007744|PDB:1Y1Z,
FT                   ECO:0007744|PDB:1Y20, ECO:0007744|PDB:2A5T,
FT                   ECO:0007744|PDB:4KCC, ECO:0007744|PDB:4KFQ,
FT                   ECO:0007744|PDB:4NF4, ECO:0007744|PDB:4NF5,
FT                   ECO:0007744|PDB:4NF6, ECO:0007744|PDB:4NF8,
FT                   ECO:0007744|PDB:4PE5, ECO:0007744|PDB:5DEX,
FT                   ECO:0007744|PDB:5I56, ECO:0007744|PDB:5I57,
FT                   ECO:0007744|PDB:5I58, ECO:0007744|PDB:5I59,
FT                   ECO:0007744|PDB:5JTY, ECO:0007744|PDB:5U8C,
FT                   ECO:0007744|PDB:5VIH, ECO:0007744|PDB:5VII,
FT                   ECO:0007744|PDB:5VIJ"
FT   DISULFID        744..798
FT                   /evidence="ECO:0007744|PDB:1PB7, ECO:0007744|PDB:1PB8,
FT                   ECO:0007744|PDB:1PB9, ECO:0007744|PDB:1PBQ,
FT                   ECO:0007744|PDB:1Y1Z, ECO:0007744|PDB:1Y20,
FT                   ECO:0007744|PDB:4KCC, ECO:0007744|PDB:4KFQ,
FT                   ECO:0007744|PDB:4NF6, ECO:0007744|PDB:4PE5,
FT                   ECO:0007744|PDB:5I56, ECO:0007744|PDB:5U8C"
FT   VAR_SEQ         190
FT                   /note="K -> KSKKRNYENLDQLSYDNKRGPK (in isoform B, isoform F
FT                   and isoform G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000140"
FT   VAR_SEQ         864..900
FT                   /note="Missing (in isoform F and isoform C)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000141"
FT   VAR_SEQ         864..885
FT                   /note="DRKSGRAEPDPKKKATFRAITS -> QYHPTDITGPLNLSDPSVSTVV (in
FT                   isoform E and isoform G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000142"
FT   VAR_SEQ         886..938
FT                   /note="Missing (in isoform E and isoform G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000143"
FT   VAR_SEQ         901..938
FT                   /note="STGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES -> QYHPTDITGP
FT                   LNLSDPSVSTVV (in isoform D)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000144"
FT   STRAND          29..32
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           36..50
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          62..65
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           71..85
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            96..99
FT                   /evidence="ECO:0007829|PDB:7YFI"
FT   HELIX           100..102
FT                   /evidence="ECO:0007829|PDB:7YFH"
FT   HELIX           105..113
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          118..122
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           127..129
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            131..133
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          138..141
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           144..146
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           149..157
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          163..170
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           171..186
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          192..197
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           205..211
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          214..216
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          218..222
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           225..237
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            238..241
FT                   /evidence="ECO:0007829|PDB:7YFI"
FT   STRAND          246..248
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            252..254
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           256..260
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          267..273
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           277..295
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            308..310
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          316..318
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           319..326
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          330..333
FT                   /evidence="ECO:0007829|PDB:7YFH"
FT   STRAND          334..336
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          338..340
FT                   /evidence="ECO:0007829|PDB:3Q41"
FT   STRAND          342..344
FT                   /evidence="ECO:0007829|PDB:3Q41"
FT   STRAND          346..348
FT                   /evidence="ECO:0007829|PDB:7YFH"
FT   STRAND          351..357
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          360..367
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          372..374
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          382..384
FT                   /evidence="ECO:0007829|PDB:7YFI"
FT   STRAND          398..402
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   TURN            406..408
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          409..413
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   TURN            416..418
FT                   /evidence="ECO:0007829|PDB:5I59"
FT   STRAND          426..428
FT                   /evidence="ECO:0007829|PDB:4NF4"
FT   STRAND          434..439
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   TURN            443..445
FT                   /evidence="ECO:0007829|PDB:7YFH"
FT   STRAND          450..457
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           458..470
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          474..478
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          480..482
FT                   /evidence="ECO:0007829|PDB:5VIH"
FT   STRAND          487..489
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          491..494
FT                   /evidence="ECO:0007829|PDB:1Y1M"
FT   STRAND          496..498
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           500..506
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          511..513
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           521..524
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          527..529
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          533..543
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   TURN            553..557
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           560..583
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           603..615
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           627..656
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          666..669
FT                   /evidence="ECO:0007829|PDB:5VII"
FT   HELIX           670..673
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          677..679
FT                   /evidence="ECO:0007829|PDB:5VIJ"
FT   STRAND          684..687
FT                   /evidence="ECO:0007829|PDB:1Y1Z"
FT   HELIX           688..694
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           697..699
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           700..706
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   TURN            707..709
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          711..713
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           714..722
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          727..732
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           733..742
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          746..748
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          753..758
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          761..763
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           769..781
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           784..792
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   STRAND          794..796
FT                   /evidence="ECO:0007829|PDB:1PB7"
FT   HELIX           811..825
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           827..840
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   MOD_RES         P35439-5:877
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P35439-7:898
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   938 AA;  105509 MW;  613D36E38F05BC73 CRC64;
     MSTMHLLTFA LLFSCSFARA ACDPKIVNIG AVLSTRKHEQ MFREAVNQAN KRHGSWKIQL
     NATSVTHKPN AIQMALSVCE DLISSQVYAI LVSHPPTPND HFTPTPVSYT AGFYRIPVLG
     LTTRMSIYSD KSIHLSFLRT VPPYSHQSSV WFEMMRVYNW NHIILLVSDD HEGRAAQKRL
     ETLLEERESK AEKVLQFDPG TKNVTALLME ARELEARVII LSASEDDAAT VYRAAAMLNM
     TGSGYVWLVG EREISGNALR YAPDGIIGLQ LINGKNESAH ISDAVGVVAQ AVHELLEKEN
     ITDPPRGCVG NTNIWKTGPL FKRVLMSSKY ADGVTGRVEF NEDGDRKFAN YSIMNLQNRK
     LVQVGIYNGT HVIPNDRKII WPGGETEKPR GYQMSTRLKI VTIHQEPFVY VKPTMSDGTC
     KEEFTVNGDP VKKVICTGPN DTSPGSPRHT VPQCCYGFCI DLLIKLARTM NFTYEVHLVA
     DGKFGTQERV NNSNKKEWNG MMGELLSGQA DMIVAPLTIN NERAQYIEFS KPFKYQGLTI
     LVKKEIPRST LDSFMQPFQS TLWLLVGLSV HVVAVMLYLL DRFSPFGRFK VNSEEEEEDA
     LTLSSAMWFS WGVLLNSGIG EGAPRSFSAR ILGMVWAGFA MIIVASYTAN LAAFLVLDRP
     EERITGINDP RLRNPSDKFI YATVKQSSVD IYFRRQVELS TMYRHMEKHN YESAAEAIQA
     VRDNKLHAFI WDSAVLEFEA SQKCDLVTTG ELFFRSGFGI GMRKDSPWKQ NVSLSILKSH
     ENGFMEDLDK TWVRYQECDS RSNAPATLTF ENMAGVFMLV AGGIVAGIFL IFIEIAYKRH
     KDARRKQMQL AFAAVNVWRK NLQDRKSGRA EPDPKKKATF RAITSTLASS FKRRRSSKDT
     STGGGRGALQ NQKDTVLPRR AIEREEGQLQ LCSRHRES
//
